Literature DB >> 22871035

Anti-obesity effects of Boussingaulti gracilis Miers var. pseudobaselloides Bailey via activation of AMP-activated protein kinase in 3T3-L1 cells.

Hana Kim1, Se-Young Choung.   

Abstract

In a previous study, we demonstrated the anti-obesity and hypolipidemic effects of Boussingaulti gracilis Miers var. pseudobaselloides Bailey in high-fat diet-induced obese rats. The present study investigated the molecular mechanisms by which B. gracilis Miers var. pseudobaselloides Bailey ethanol extract (BGE) conferred antidifferentiation and anti-adipogenic effects in the 3T3-L1 preadipocyte differentiation model. BGE treatment significantly and dose-dependently suppressed lipid accumulation and down-regulated the expression of major transcription factors involved in adipogenesis, such as peroxisome proliferator-activated receptor-γ, CCAAT/enhancer binding protein α, sterol regulatory element-binding proteins, and their target genes. It is important that treatment with BGE increased phosphorylation of AMP-activated protein kinase (AMPK), which is one of the rate-limiting enzymes in the fatty acid synthesis pathway, and its direct downstream protein, acetyl-coenzyme A carboxylase. These results suggest that BGE may exert anti-adipogenic effects through regulation of AMPK activity and expression of genes involved in lipogenesis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22871035      PMCID: PMC3429298          DOI: 10.1089/jmf.2011.2126

Source DB:  PubMed          Journal:  J Med Food        ISSN: 1096-620X            Impact factor:   2.786


  25 in total

1.  In vitro anti-herpes simplex viruses and anti-adenoviruses activity of twelve traditionally used medicinal plants in Taiwan.

Authors:  Lien-Chai Chiang; Hua-Yew Cheng; Mei-Chi Liu; Wen Chiang; Chun-Ching Lin
Journal:  Biol Pharm Bull       Date:  2003-11       Impact factor: 2.233

Review 2.  AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome.

Authors:  Neil Ruderman; Marc Prentki
Journal:  Nat Rev Drug Discov       Date:  2004-04       Impact factor: 84.694

Review 3.  The AMP-activated protein kinase--fuel gauge of the mammalian cell?

Authors:  D G Hardie; D Carling
Journal:  Eur J Biochem       Date:  1997-06-01

Review 4.  Sibutramine: a serotonin-norepinephrine reuptake-inhibitor for the treatment of obesity.

Authors:  C A Luque; J A Rey
Journal:  Ann Pharmacother       Date:  1999-09       Impact factor: 3.154

Review 5.  Inflammation, stress, and diabetes.

Authors:  Kathryn E Wellen; Gökhan S Hotamisligil
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

6.  Lipogenic enzymes fatty acid synthase and acetyl-coenzyme A carboxylase are coexpressed with sterol regulatory element binding protein and Ki-67 in fetal tissues.

Authors:  R E Wilentz; L A Witters; E S Pizer
Journal:  Pediatr Dev Pathol       Date:  2000 Nov-Dec

7.  Sterol regulatory element binding protein 1c (SREBP-1c) expression in human obesity.

Authors:  M Kolehmainen; H Vidal; E Alhava; M I Uusitupa
Journal:  Obes Res       Date:  2001-11

8.  Resveratrol improves non-alcoholic fatty liver disease by activating AMP-activated protein kinase.

Authors:  Jing Shang; Lu-lu Chen; Fang-xi Xiao; Hui Sun; Hong-cheng Ding; Hu Xiao
Journal:  Acta Pharmacol Sin       Date:  2008-06       Impact factor: 6.150

9.  [Resveratrol improves high-fat induced nonalcoholic fatty liver in rats].

Authors:  Jing Shang; Lu-Lu Chen; Fang-Xi Xiao
Journal:  Zhonghua Gan Zang Bing Za Zhi       Date:  2008-08

Review 10.  Lipid overload and overflow: metabolic trauma and the metabolic syndrome.

Authors:  Roger H Unger
Journal:  Trends Endocrinol Metab       Date:  2003-11       Impact factor: 12.015

View more
  6 in total

1.  Essential Oil of Pinus koraiensis Exerts Antiobesic and Hypolipidemic Activity via Inhibition of Peroxisome Proliferator-Activated Receptors Gamma Signaling.

Authors:  Hyun-Suk Ko; Hyo-Jeong Lee; Hyo-Jung Lee; Eun Jung Sohn; Miyong Yun; Min-Ho Lee; Sung-Hoon Kim
Journal:  Evid Based Complement Alternat Med       Date:  2013-08-13       Impact factor: 2.629

2.  Corni Fructus Containing Formulation Attenuates Weight Gain in Mice with Diet-Induced Obesity and Regulates Adipogenesis through AMPK.

Authors:  Hye-Lin Kim; Yong-Deok Jeon; Jinbong Park; Hong-Kun Rim; Mi-Young Jeong; Hara Lim; Seong-Gyu Ko; Hyeung-Jin Jang; Byung-Cheol Lee; Kyung-Tae Lee; Kang-Min Lee; Hyejung Lee; Sung-Hoon Kim; Su-Jin Kim; Seung-Heon Hong; Jae-Young Um
Journal:  Evid Based Complement Alternat Med       Date:  2013-09-19       Impact factor: 2.629

3.  Chrysophanic Acid Suppresses Adipogenesis and Induces Thermogenesis by Activating AMP-Activated Protein Kinase Alpha In vivo and In vitro.

Authors:  Hara Lim; Jinbong Park; Hye-Lin Kim; JongWook Kang; Mi-Young Jeong; Dong-Hyun Youn; Yunu Jung; Yong-Il Kim; Hyun-Ju Kim; Kwang Seok Ahn; Su-Jin Kim; Seong-Kyu Choe; Seung-Heon Hong; Jae-Young Um
Journal:  Front Pharmacol       Date:  2016-12-08       Impact factor: 5.810

Review 4.  Biogenic Phytochemicals Modulating Obesity: From Molecular Mechanism to Preventive and Therapeutic Approaches.

Authors:  Vikram Kumar; Desh Deepak Singh; Sudarshan Singh Lakhawat; Nusrath Yasmeen; Aishwarya Pandey; Rajeev K Singla
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-27       Impact factor: 2.629

5.  Veratri Nigri Rhizoma et Radix (Veratrum nigrum L.) and Its Constituent Jervine Prevent Adipogenesis via Activation of the LKB1-AMPKα-ACC Axis In Vivo and In Vitro.

Authors:  Jinbong Park; Yong-Deok Jeon; Hye-Lin Kim; Dae-Seung Kim; Yo-Han Han; Yunu Jung; Dong-Hyun Youn; JongWook Kang; Daeyeon Yoon; Mi-Young Jeong; Jong-Hyun Lee; Seung-Heon Hong; Junhee Lee; Jae-Young Um
Journal:  Evid Based Complement Alternat Med       Date:  2016-04-06       Impact factor: 2.629

6.  Effects of dietary energy level on appetite and central adenosine monophosphate-activated protein kinase (AMPK) in broilers.

Authors:  Xiyi Hu; Yufeng Wang; Ardashir Sheikhahmadi; Xianlei Li; Johan Buyse; Hai Lin; Zhigang Song
Journal:  J Anim Sci       Date:  2019-11-04       Impact factor: 3.159

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.